$宝济药业-B(02_老虎社区_美港股上老虎

$宝济药业-B(02659)$ 宝济药业-B在竞争中形成了基于大容量皮下注射和重组蛋白技术的多元化产品组合，并积极推动研产销一体化转型，通过建设大规模产业化能力及优化供应链，为后续创新药注册及商业化奠定基础

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":558867917603032,"tweetId":"558867917603032","gmtCreate":1777474056904,"gmtModify":1777474059052,"author":{"id":3574483855983034,"idStr":"3574483855983034","authorId":3574483855983034,"authorIdStr":"3574483855983034","name":"行稳致远之","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":2,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","individualDisplayEnabled":0},"individualDisplayBadges":[],"wearingBadges":[{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","name":"实盘交易者","description":"完成一笔实盘交易","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","isScarce":0,"effectEnabled":0,"redirectLinkEnabled":0,"redirectLinkValidityFrom":0,"redirectLinkValidityTo":9223372036854776000}],"fanSize":27,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"title":"","html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02659\">$宝济药业-B(02659)$</a> 宝济药业-B在竞争中形成了基于大容量皮下注射和重组蛋白技术的多元化产品组合，并积极推动研产销一体化转型，通过建设大规模产业化能力及优化供应链，为后续创新药注册及商业化奠定基础</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/02659\">$宝济药业-B(02659)$</a> 宝济药业-B在竞争中形成了基于大容量皮下注射和重组蛋白技术的多元化产品组合，并积极推动研产销一体化转型，通过建设大规模产业化能力及优化供应链，为后续创新药注册及商业化奠定基础</p></body></html>","text":"$宝济药业-B(02659)$ 宝济药业-B在竞争中形成了基于大容量皮下注射和重组蛋白技术的多元化产品组合，并积极推动研产销一体化转型，通过建设大规模产业化能力及优化供应链，为后续创新药注册及商业化奠定基础","highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/558867917603032","repostId":0,"isVote":1,"tweetType":1,"viewCount":153,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["02659"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":188,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/558867917603032"}